← Open Payments lookup

MARCO RENAZCO: Open Payments

NPI 1518038751 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,521 in 75 payments from 19 companies in 2025. Trend: 2023 $1,410 · 2024 $1,114 · 2025 $1,521

Food & beverage: $1,521
CompanyPaymentsAmount
ABBVIE INC.16$265
Otsuka America Pharmaceutical, Inc.8$173
E.R. Squibb & Sons, L.L.C.4$108
Vanda Pharmaceuticals Inc.6$104
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$98
Vertical Pharmaceuticals, LLC5$97
Tris Pharma Inc4$86
Axsome Therapeutics, Inc.3$76
Corium, LLC5$74
Bausch Health US, LLC3$63

Products named: VRAYLAR, REXULTI, COBENFY, FANAPT, CAPLYTA, Relexxii, Dyanavel XR, Auvelity.

Industry payments across TX — which companies pay providers there.